DoseOptics LLC

DoseOptics manufactures BeamSite, an FDA-cleared Cherenkov imaging system that captures real-time video visualization of radiation therapy dose delivery to patients during treatment. BeamSite is the first clinical system to provide direct visual verification of radiotherapy beam placement and dose delivery by imaging Cherenkov light emissions. The company offers two product lines: BeamSite for clinical use in radiation oncology departments, and BeamSite Research for laboratory and research applications. By enabling clinicians to visually verify radiation therapy in real time, BeamSite supports treatment quality assurance, reduces delivery errors, and enhances patient safety. Clinical evidence demonstrates that visualization can identify suboptimal treatments that would otherwise go undetected. DoseOptics also partners with Vision RT to offer DoseRT, a Cherenkov imaging system integrated with Surface-Guided Radiation Therapy (SGRT) technology. The company serves radiation oncologists, medical physicists, radiation therapists, hospital administrators, and research institutions.